Carillion PLC
20 December 2004
Carillion secures Canadian contracts worth £100 million
Support services and construction company Carillion has secured work with a
total value of £100 million in Canada.
Royal Ottawa Hospital
In joint venture with its two partners, Carillion has reached financial close
for the new state of the art Royal Ottawa Hospital, Canada, to be built under
the Public Private Partnership (PPP).
This is the second Canadian hospital project in Ontario to be delivered by The
Healthcare Infrastructure Company of Canada who will finance, design, build,
property manage, maintain and provide non-clinical services at the facility.
In addition to investing equity in the 188-bed hospital, education and research
facility, the project is expected to generate £63 million of construction and
facilities management turnover for Carillion over the 20-year life of the
concession.
The redevelopment of the Royal Ottawa Hospital will see it evolve from an acute
psychiatric hospital serving Ottawa - Canada's capital region - into a highly
specialised tertiary and research facility for people with severe and persistent
mental illness throughout Eastern Ontario.
The delivery of mental health services remains the responsibility of the
hospital board.
Roads maintenance
In addition, Carillion Canada's road maintenance joint venture, TWD, has been
named preferred bidder on the £36 million Hamilton area maintenance contract by
the Ministry of Transportation of Ontario.
Consisting of 648, two-lane equivalent kilometres of highways around the Golden
Horseshoe communities of Toronto, Burlington, Oakville, Vaughan, Hamilton and
Brantford, the contract includes year-round maintenance, summer and winter road
patrolling, vegetation management and maintenance of illumination and traffic
lights.
Commenting on these successes, Carillion's chief executive John McDonough said,
'We are delighted to have reached financial close on The Royal Ottawa Hospital,
our second PPP project in Canada and to have been appointed as the preferred
bidder for another highways maintenance contract in Ontario.
'Developing our healthcare and transport businesses through transferring our
public private partnership and business services skills to our international
regions are a key part of our strategy for growth. Having recently reached
financial close on Canada's first PPP hospital, the new William Osler Hospital,
in Toronto, our success with the Royal Ottawa has established Carillion as a
leader in this important market. We look forward to working with the Royal
Ottawa Hospital to provide a state of the art hospital and research facility
together with the services necessary to support the delivery of first class
healthcare.
'Our highways maintenance business in now the largest in Ontario having won
contracts worth a total of £200m. We shall continue to work closely with the
Province of Ontario to provide high quality value for money services focused on
the needs of road users.'
Note to editors
The Healthcare Infrastructure Company of Canada, comprises Carillion Canada,
Borealis Infrastructure Management and the EllisDon Corporation.
Last month, a Carillion-led consortium reached financial close to finance,
design, build, property manage, maintain and provide non-clinical services at
the new 608-bed William Osler Health Centre in Brampton, Ontario, the first to
be procured as an AFP project. It is expected to generate around £420 million of
construction and facilities management turnover over the 25-year concession for
Carillion, in addition to the returns Carillion will get on its equity
investment in the project.
Carillion is also the preferred bidder on four other PPP projects - the Queen
Alexandra Hospital in Portsmouth, a schools projects in Renfrewshire, an
Independent Sector Treatment Centre in Basildon and a social housing project in
North East Derbyshire, together worth £1.2 billion.
For further information contact
John Denning, Director Group Corporate Affairs 01902 316384
Paula Manning, Corporate Communications 01902 316444
This information is provided by RNS
The company news service from the London Stock Exchange
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.